FDA – Page 67 – Pharma.Tips

Data exclusivity lapse risk during development – business and regulatory impact analysis

Assessing the Impact of Data Exclusivity Lapse Risk During Development In pharmaceutical development, maintaining data exclusivity is critical for protecting intellectual property rights and ensuring a favorable competitive landscape. However,…

Supplier change unqualified during transportation – CAPA and system remediation

Investigating Unqualified Supplier Changes During Transportation: CAPA and Remediation Strategies In the pharmaceutical industry, ensuring that all aspects of the supply chain are qualified is crucial for compliance and patient…

User account governance failures during validation lifecycle – preventing repeat CSV observations

Addressing User Account Governance Failures During the Validation Lifecycle in Pharma Operations User account governance failures pose a significant risk in pharmaceutical operations, particularly during the validation lifecycle. This issue…

Excursion trend ignored during storage – product quality risk assessment

Assessing Product Quality Risks from Ignored Excursion Trends During Storage In the highly regulated world of pharmaceutical manufacturing, maintaining product quality throughout the supply chain is paramount. One of the…

Interface validation gaps during system operation – preventing repeat CSV observations

Addressing Gaps in Interface Validation During System Operations to Prevent Repeat CSV Findings Interface validation gaps during system operation pose significant risks to data integrity and GMP compliance within pharmaceutical…

Supplier change unqualified during transportation – how to prevent repeat excursions

Addressing Unqualified Supplier Changes During Transportation to Prevent Future Excursions In the dynamic environment of pharmaceutical manufacturing and logistics, the transportation of materials is critical. A concerning scenario emerges when…

Interface validation gaps during inspection walkthrough – inspection evidence pack preparation

Addressing Interface Validation Gaps During Inspection Walkthroughs During inspections, regulatory bodies frequently identify interface validation gaps that can jeopardize data integrity and compliance with Good Manufacturing Practices (GMP). This article…

Distribution temperature breach during audit – product quality risk assessment

Assessing the Risks of Temperature Breach in Distribution During an Audit Temperature breaches during product distribution can pose significant risks to pharmaceutical product quality. Such events may trigger regulatory scrutiny…

Audit trail gaps identified during validation lifecycle – FDA/EMA expectations for computerized systems

“`html Identifying Audit Trail Gaps During the Validation Lifecycle: FDA/EMA Expectations for Computerized Systems In the highly regulated pharmaceutical environment, maintaining data integrity and compliance throughout the validation lifecycle is…

Supplier change unqualified during inspection – how to prevent repeat excursions

Preventing Repeat Excursions from Unqualified Supplier Changes During Inspections In the fast-paced environment of pharmaceutical manufacturing, the integrity of the supply chain is crucial to maintain quality and compliance. Supplier…

System access control failure during inspection walkthrough – preventing repeat CSV observations

Understanding System Access Control Failures During Inspection Walkthroughs In the pharmaceutical industry, system access control is paramount for ensuring data integrity and compliance during regulatory audits. Breaches in this area…

Distribution temperature breach during transportation – how to prevent repeat excursions

Addressing Distribution Temperature Breaches During Transportation: Effective Prevention Strategies Distribution temperature breaches during transportation pose significant risks to pharmaceuticals, potentially compromising product quality and patient safety. This article outlines a…